Drug targeting and tumor heterogeneity

被引：171

作者：

Bae, You Han ^{[1
]}

机构：

[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA

来源：

JOURNAL OF CONTROLLED RELEASE | 2009年 / 133卷 / 01期

关键词：

D O I：

10.1016/j.jconrel.2008.09.074

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：2 / 3

页数：2

共 5 条

[1]

Greller LD, 1996, INVAS METAST, V16, P177

[2] Folate receptor overexpression is associated with poor outcome in breast cancer [J].

Hartmann, Lynn C. ;

Keeney, Gary L. ;

Lingle, Wilma L. ;

Christianson, Teresa J. H. ;

Varghese, Bindu ;

Hillman, David ;

Oberg, Ann L. ;

Low, Philip S. .

INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :938-942

[3] Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment [J].

Hobbs, SK ;

Monsky, WL ;

Yuan, F ;

Roberts, WG ;

Griffith, L ;

Torchilin, VP ;

Jain, RK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4607-4612

[4] Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles [J].

Hwang, Ho-Young ;

Kim, In-San ;

Kwon, Ick Chan ;

Kim, Yong-Hee .

JOURNAL OF CONTROLLED RELEASE, 2008, 128 (01) :23-31

[5] Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review [J].

Maeda, H ;

Wu, J ;

Sawa, T ;

Matsumura, Y ;

Hori, K .

JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :271-284

← 1 →